Protocol Details

Collection of Blood from Therapeutic Trial Participants for Analysis of Genetic Differences in Drug Disposition and Pharmacokinetics of Probe Medications

This study is currently recruiting participants.

Summary | Eligibility | Citations | Contacts

Summary

Number

11-C-0242

Sponsoring Institute

National Cancer Institute (NCI)

Recruitment Detail

Type: Participants currently recruited/enrolled
Gender: Male & Female
Min Age: 3 Years
Max Age: N/A

Referral Letter Required

Yes

Population Exclusion(s)

None

Keywords

Pharmacogenetics;
Pharmacokinetics;
Pharmacodynamics;
Clinical Outcome;
Drug Metabolism and Transport;
Natural History

Recruitment Keyword(s)

Cancer

Condition(s)

Prostate Cancer;
Breast Cancer;
Lung Cancer;
Ovarian Cancer;
Lymphoma

Investigational Drug(s)

None

Investigational Device(s)

None

Intervention(s)

None

Supporting Site

National Cancer Institute

Background:

- Some genes may be associated with a greater chance of side effects during cancer treatment. These genes may also make certain treatments less effective. Researchers want to collect blood or cheek swab samples from people having cancer treatment to study these genes.

Objectives:

- To obtain a blood or cheek swab sample to study genetic differences that may affect cancer treatment.

Eligibility:

- Individuals with cancer who are being treated at the National Cancer Institute.

Design:

- Participants will provide a blood sample for study.

- Participants who have blood-based cancer, such as leukemia, will provide a cheek swab sample.

- If the blood or cheek swab sample does not have enough genetic material for analysis, an additional sample may be collected.

Eligibility

INCLUSION CRITERIA:

-Any individual currently enrolled in an NIH intramural research program clinical trials receiving treatment.

-Ability of participant or Legally Authorized Representative (LAR) to understand and be willing to sign the informed consent document.

-Age >= 3 years old

EXCLUSION CRITERIA:

-N/A


Citations:

Not Provided

Contacts:

Principal Investigator

Referral Contact

For more information:

William D. Figg, Pharm.D.
National Cancer Institute (NCI)
National Institutes of Health
Building 10
Room 5A01
10 Center Drive
Bethesda, Maryland 20892
(240) 760-6179
figgw@mail.nih.gov
Deneise C. Francis, R.N.
National Cancer Institute (NCI)
National Institutes of Health
Building 10
Room 13N222
10 Center Drive
Bethesda, Maryland 20892
(240) 858-3974
deneise.francis@nih.gov
NCI Referral Office
National Institute of Health Clinical Center (CC), 9000 Rockville Pike, Bethesda, Maryland 20892, United States: NCI Clinical Trials Referral Office
(888) 624-1937
ncimo_referrals@mail.nih.gov

Clinical Trials Number:

NCT01441089
Was this page helpful?